(Q44161423)

English

Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy

scientific article published in August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy (English)

1 reference

Europe PubMed Central

30 November 2017

Plasmodium vivax

0 references

Jetsumon Sattabongkot

6

object named as

Jetsumon Sattabongkot

1 reference

Europe PubMed Central

30 November 2017

Takafumi Tsuboi

object named as

Takafumi Tsuboi

8

0 references

author name string

Darin Kongkasuriyachai

1

1 reference

Europe PubMed Central

30 November 2017

Lucy Bartels-Andrews

2

1 reference

Europe PubMed Central

30 November 2017

Anthony Stowers

3

1 reference

Europe PubMed Central

30 November 2017

William E Collins

4

1 reference

Europe PubMed Central

30 November 2017

JoAnn Sullivan

5

1 reference

Europe PubMed Central

30 November 2017

Motomi Torii

7

1 reference

Europe PubMed Central

30 November 2017

Nirbhay Kumar

9

1 reference

Europe PubMed Central

30 November 2017

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

22

1 reference

Europe PubMed Central

30 November 2017

23-24

1 reference

Europe PubMed Central

30 November 2017

3205-3213

1 reference

Europe PubMed Central

30 November 2017

Antimalarial drugs and the mosquito transmission of Plasmodium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

DNA vaccination strategies against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

Development of a method for the in vitro production of Plasmodium vivax ookinetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.060

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.11.060

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44161423&oldid=2107302565"